Home This week in gene and cell therapy - 18 May 2018 Gene and cell therapy headlines 14 - 18 May Michele De Luca and Alexander Meissner elected to EMBO membership David Liu, Feng Zhand and Keith Joung launch new company, Beam Therapeutics Concerns grow over DIY gene editing "biohackers" NovoNordisk announces partnership with BioLamina to bolster cell therapy Calls for patient registries of gene and cell therapy clinical trials Cell and Gene Therapy Catapult annonces funding to promote integration of gene and cell therapy into UK health services TapImmune and Marker Therapeutics merge to develop new T cell therapies Bioverativ Inc' BIVV003, a gene-edited cell therapy candidate for sickle cell disease obtains IND status from the FDA